LONDON–(BUSINESS WIRE)–#GlobalOpioidInducedConstipationMarket–Technavio has been monitoring the opioid-induced constipation market and it is poised to grow by USD 3.39 billion during 2020-2024, progressing at a CAGR of over 21% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. We offer $1000 worth of FREE customization

The market is concentrated, and the degree of concentration will accelerate during the forecast period. AstraZeneca Plc, Bausch Health Companies Inc., Daiichi Sankyo Co. Ltd., Ironwood Pharmaceuticals Inc., Mallinckrodt Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., SHIONOGI Co. Ltd., and Takeda Pharmaceutical Co. Ltd. (Read more…) are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Increase in opioid prescriptions globally has been instrumental in driving the growth of the market. However, the use of conventional laxatives for opioid-induced constipation might hamper the market growth.

Technavio’s custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Download a Free Sample Report on COVID-19 Impacts

Opioid-Induced Constipation Market 2020-2024: Segmentation

Opioid-Induced Constipation Market is segmented as below:

• Route of administration
  • Oral
  • Parenteral
• Class of drugs
  • Peripherally Acting Mu-opioid Receptor Antagonists
  • Locally Acting Chloride Channel Activator
  • Others
• Geography
  • North America
  • Europe
  • Asia
  • ROW

Opioid-Induced Constipation Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The opioid-induced constipation market report covers the following areas:

• Opioid-Induced Constipation Market Size
• Opioid-Induced Constipation Market Trends
• Opioid-Induced Constipation Market Industry Analysis

This study identifies the rise in the incidence of chronic diseases such as arthritis, back pain, and migraine as one of the prime reasons driving the Opioid-Induced Constipation Market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

Opioid-Induced Constipation Market 2020-2024: Key Highlights

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will assist opioid-induced constipation market growth during the next five years
• Estimation of the opioid-induced constipation market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the opioid-induced constipation market
• Analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of opioid-induced constipation market vendors

Table of Contents:

Executive Summary

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2019
• Market outlook: Forecast for 2019 – 2024

Five Forces Analysis

• Five forces summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Route of Administration

• Market segments
• Comparison by route of administration
• Oral – Market size and forecast 2019-2024
• Parenteral – Market size and forecast 2019-2024
• Market opportunity by route of administration

Market Segmentation by Class of Drugs

• Peripherally acting mu-opioid receptor antagonists
• Locally acting chloride channel activator
• Other drugs

Customer landscape

• Overview

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Overview
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• AstraZeneca Plc
• Bausch Health Companies Inc.
• Daiichi Sankyo Co. Ltd.
• Ironwood Pharmaceuticals Inc.
• Mallinckrodt Plc
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• SHIONOGI Co. Ltd.
• Takeda Pharmaceutical Co. Ltd.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: [email protected]
Website: www.technavio.com/

LONDON–(BUSINESS WIRE)–#GlobalOpioidInducedConstipationMarket–Technavio has been monitoring the opioid-induced constipation market and it is poised to grow by USD 3.39 billion during 2020-2024, progressing at a CAGR of over 21% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. We offer $1000 worth of FREE customization

The market is concentrated, and the degree of concentration will accelerate during the forecast period. AstraZeneca Plc, Bausch Health Companies Inc., Daiichi Sankyo Co. Ltd., Ironwood Pharmaceuticals Inc., Mallinckrodt Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., SHIONOGI Co. Ltd., and Takeda Pharmaceutical Co. Ltd. (Read more…) are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Increase in opioid prescriptions globally has been instrumental in driving the growth of the market. However, the use of conventional laxatives for opioid-induced constipation might hamper the market growth.

Technavio’s custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Download a Free Sample Report on COVID-19 Impacts

Opioid-Induced Constipation Market 2020-2024: Segmentation

Opioid-Induced Constipation Market is segmented as below:

• Route of administration
  • Oral
  • Parenteral
• Class of drugs
  • Peripherally Acting Mu-opioid Receptor Antagonists
  • Locally Acting Chloride Channel Activator
  • Others
• Geography
  • North America
  • Europe
  • Asia
  • ROW

Opioid-Induced Constipation Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The opioid-induced constipation market report covers the following areas:

• Opioid-Induced Constipation Market Size
• Opioid-Induced Constipation Market Trends
• Opioid-Induced Constipation Market Industry Analysis

This study identifies the rise in the incidence of chronic diseases such as arthritis, back pain, and migraine as one of the prime reasons driving the Opioid-Induced Constipation Market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

Opioid-Induced Constipation Market 2020-2024: Key Highlights

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will assist opioid-induced constipation market growth during the next five years
• Estimation of the opioid-induced constipation market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the opioid-induced constipation market
• Analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of opioid-induced constipation market vendors

Table of Contents:

Executive Summary

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2019
• Market outlook: Forecast for 2019 – 2024

Five Forces Analysis

• Five forces summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Route of Administration

• Market segments
• Comparison by route of administration
• Oral – Market size and forecast 2019-2024
• Parenteral – Market size and forecast 2019-2024
• Market opportunity by route of administration

Market Segmentation by Class of Drugs

• Peripherally acting mu-opioid receptor antagonists
• Locally acting chloride channel activator
• Other drugs

Customer landscape

• Overview

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Overview
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• AstraZeneca Plc
• Bausch Health Companies Inc.
• Daiichi Sankyo Co. Ltd.
• Ironwood Pharmaceuticals Inc.
• Mallinckrodt Plc
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• SHIONOGI Co. Ltd.
• Takeda Pharmaceutical Co. Ltd.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: [email protected]
Website: www.technavio.com/